| Price | 6.95p on 13-05-2026 at 16:15:00 |
|---|---|
| Change | 0.00p 0% |
| Buy | 7.10p |
| Sell | 6.80p |
| Last Trade: | Sell 28,992.00 at 6.8668p |
| Day's Volume: | 371,637 |
| Last Close: | 6.95p |
| Open: | 6.95p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.95p - 6.95p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £74.26m |
| VWAP: | 6.893605p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 28,992 | 6.8668p | Ordinary |
16:23:50 - 13-May-26 |
| Buy* | 11 | 7.08p | Ordinary |
16:20:45 - 13-May-26 |
| Buy* | 52,756 | 7.00p | Ordinary |
16:15:48 - 13-May-26 |
| Sell* | 10,000 | 6.911p | Ordinary |
15:52:03 - 13-May-26 |
| Sell* | 19,000 | 6.80p | Ordinary |
15:45:14 - 13-May-26 |
| Sell* | 40,727 | 6.875p | Ordinary |
15:44:33 - 13-May-26 |
| Sell* | 2,628 | 6.911p | Ordinary |
15:07:26 - 13-May-26 |
| Sell* | 144 | 6.944p | Ordinary |
14:16:46 - 13-May-26 |
| Sell* | 5,846 | 6.911p | Ordinary |
12:48:01 - 13-May-26 |
| Buy* | 8,835 | 7.10p | Ordinary |
12:23:51 - 13-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
